Literature DB >> 28338925

Tobacco Use, Oral Health, and Risk of Parkinson's Disease.

Zhiwei Liu, Ann Roosaar, Tony Axéll, Weimin Ye.   

Abstract

Few studies have investigated the associations between use of Swedish moist snuff (snus), associated poor oral health, and risk of Parkinson's disease (PD). We followed 20,175 participants who were free of PD in 1973-1974 in Uppsala, Sweden, until the end of 2012. We used Cox proportional hazards regression models to estimate hazard ratios and corresponding 95% confidence intervals for the associations between tobacco use, oral health indicators, and PD risk. We found that tobacco use was associated with a lower risk of PD in males. Compared with males who never used any tobacco daily, pure ever tobacco smokers, pure ever snus users, and combined users had adjusted hazard ratios of 0.68 (95% confidence interval (CI): 0.49, 0.93; n = 83), 0.51 (95% CI: 0.27, 0.95; n = 11), and 0.21 (95% CI: 0.07, 0.67; n = 3), respectively. No association was observed for number of teeth, dental plaque, or detectable oral mucosal lesions and PD risk, although there was a suggestive association with Candida-related oral mucosal lesions in males (hazard ratio = 1.56, 95% CI: 0.92, 2.65; P = 0.098). Use of snus is associated with a lower risk of PD in males, while poor oral health seems not to be associated with PD occurrence.
© The Author 2017. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Parkinson's disease; cohort studies; oral health; smoking; snus; tobacco

Mesh:

Year:  2017        PMID: 28338925     DOI: 10.1093/aje/kww146

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  7 in total

1.  Evidence-Based Recommendations for the Oral Health of Patients with Parkinson's Disease.

Authors:  Ana L C Martimbianco; Fabio C Prosdocimi; Camillo Anauate-Netto; Elaine M Dos Santos; Gustavo D Mendes; Yara D Fragoso
Journal:  Neurol Ther       Date:  2021-03-18

Review 2.  Novel Pharmacotherapies in Parkinson's Disease.

Authors:  Yousef Tizabi; Bruk Getachew; Michael Aschner
Journal:  Neurotox Res       Date:  2021-05-18       Impact factor: 3.911

Review 3.  Nicotine from cigarette smoking and diet and Parkinson disease: a review.

Authors:  Chaoran Ma; Yesong Liu; Samantha Neumann; Xiang Gao
Journal:  Transl Neurodegener       Date:  2017-07-02       Impact factor: 8.014

4.  The oral microbiome of early stage Parkinson's disease and its relationship with functional measures of motor and non-motor function.

Authors:  Dragos Mihaila; Jordan Donegan; Sarah Barns; Daria LaRocca; Qian Du; Danny Zheng; Michael Vidal; Christopher Neville; Richard Uhlig; Frank A Middleton
Journal:  PLoS One       Date:  2019-06-27       Impact factor: 3.240

5.  A nationwide study of the incidence, prevalence and mortality of Parkinson's disease in the Norwegian population.

Authors:  Brage Brakedal; Lilah Toker; Kristoffer Haugarvoll; Charalampos Tzoulis
Journal:  NPJ Parkinsons Dis       Date:  2022-03-02

6.  Molar loss induces hypothalamic and hippocampal astrogliosis in aged mice.

Authors:  Masae Furukawa; Hirobumi Tada; Jingshu Wang; Mitsuyoshi Yamada; Mie Kurosawa; Akiko Satoh; Noboru Ogiso; Yosuke Shikama; Kenji Matsushita
Journal:  Sci Rep       Date:  2022-04-18       Impact factor: 4.996

Review 7.  The Changing Landscape of Parkinson Epidemiologic Research.

Authors:  Honglei Chen
Journal:  J Parkinsons Dis       Date:  2018       Impact factor: 5.568

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.